{"id":"W2117159275","doi":"10.1111/j.1365-2133.2011.10775.x","title":"Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial","year":2011,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":92,"is_retracted":false,"has_abstract":true,"ca_institutions":"Windsor Clinical Research; Welichem Biotech (Canada); University of British Columbia; Centre de Recherche Dermatologique du Québec Métropolitain; Innovaderm (Canada)","funders":"","keywords":"Placebo; Medicine; Atopic dermatitis; Internal medicine; Randomized controlled trial; Randomization; Clinical endpoint; Confidence interval; Double blind; Gastroenterology; Dermatology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002566082,0.0002137234,0.00203529,0.0002428106,0.00005804473,0.00001736271,0.0001725507,0.0002565606,0.0000941886],"category_scores_gemma":[0.001033207,0.0001816831,0.0002061641,0.0001163809,0.0002713715,0.0001605751,0.00005761765,0.0003939637,0.000004925452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003100402,"about_ca_system_score_gemma":0.0001649441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002534219,"about_ca_topic_score_gemma":0.0003534853,"domain_scores_codex":[0.9968069,0.0005620422,0.00174843,0.0002574707,0.0003018018,0.0003233446],"domain_scores_gemma":[0.9976312,0.0009423865,0.0006714847,0.000195574,0.0002372454,0.0003220962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9084746,0.001502936,0.08363154,0.00004374205,0.0005481322,0.002768085,0.0009837268,0.000002323373,6.787386e-7,0.00002113526,0.0008701865,0.001152899],"study_design_scores_gemma":[0.7064909,0.0002858291,0.2876672,0.0006055333,0.000448,0.004087973,0.0001015216,0.00001337406,0.00006608983,0.00005611037,0.0000546162,0.0001227891],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944014,0.00106024,0.00008875762,0.0005823345,0.0002592621,0.002498305,0.00003825865,0.00001137204,0.001060096],"genre_scores_gemma":[0.9981195,0.0002089223,0.001111655,0.0003878728,0.00006327182,0.00003086625,0.00002997637,0.00001647768,0.00003147232],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2040357,"threshold_uncertainty_score":0.740882,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02073584318858101,"score_gpt":0.253027453172948,"score_spread":0.232291609984367,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}